A triplet combination with Irinotecan (CPT-11) plus Oxaliplatin (L-OHP), continuous infusion 5-fluorouracil (5-FU) and Leucovorin (LV) (FOLFOXIRI) plus Cetuximab (C-225) as first line treatment in metastatic colorectal cancer (MCC) : A pilot phase II trial.
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2520677
下载链接
链接失效反馈官方服务：
资源简介：
Primary objectives: •Objective Response Rate
主要研究目标：• 客观缓解率（Objective Response Rate）
创建时间：
2007-05-15
